Galena Biopharma (GALE) announced today the resignation of CEO Mark Ahn and the instillation of COO, Mark Schwartz as its new CEO. In reaction …
BioLineRx Ltd. (BLRX) today announced it received a Notice of Allowance of US patent for its Celiac disease candidate drug, BL-7010.
Cytori Therapeutics (NASDAQ:CYTX) announced that BARDA executed the option to fund the continued development of Cytori Cell Therapy for thermal burn injuries. The current …
TG Therapeutics (TGTX) announced the initiation of a novel three drug combination study assessing the chemo-free combination of TG-1101 + TGR-1202 + Imbruvica. …
Regeneron Pharmaceuticals (REGN) announced that Eylea has been approved by the European Commission for use in patients with DME. Marketing of Eylea will be initiated …
In a research note published August 11, Roth Capital analyst Joseph Pantginis issued a note in which he reiterated a Buy rating on Peregrine Pharmaceuticals (PPHM) with …
In a research note published August 8, Roth Capital analyst Joseph Pantginis issued a note in which he reiterated a Buy rating on Spectrum …
In a research note published August 8th, Roth Capital analyst Joseph Pantginis maintained a Buy rating on ImmunoCellular Therapeutics (IMUC) with a $3 …
In a research report released yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Celldex Therapeutics (CLDX) with a $40 price …
In a research note published yesterday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Synta Pharmaceuticals (SNTA) with a $27 price …
